Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions-Reference-Cited by-同舟云学术

Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions

Published:2021-09 Issue: Volume:159 Page:66-73
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Mondaca Sebastian,Lebow Emily S.,Namakydoust Azadeh,Razavi Pedram,Reis-Filho Jorge S.,Shen Ronglai,Offin Michael,Tu Hai-Yan,Murciano-Goroff Yonina,Xu Chongrui,Makhnin Alex,Martinez Andres,Pavlakis Nick,Clarke Stephen,Itchins Malinda,Lee Adrian,Rimner Andreas,Gomez Daniel,Rocco Gaetano,Chaft Jamie E.,Riely Gregory J.,Rudin Charles M.,Jones David R.,Li Mark,Shaffer Tristan,Hosseini Seyed Ali,Bertucci Caterina,Lim Lee P.,Drilon Alexander,Berger Michael F.,Benayed Ryma,Arcila Maria E.,Isbell James M.,Li Bob T.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

2. ALK fusion partners impact response to ALK inhibition: differential effects on sensitivitcy, cellular phenotypes, and biochemical properties;Childress;Mol. Cancer Res.,2018

3. Comprehensive genomic profiling identifies a subset of crizotinib-responsive ALK-rearranged non-small cell lung cancer not detected by fluorescence in situ hybridization;Ali;Oncologist,2016

4. ALK fusions in a wide variety of tumor types respond to anti-ALK targeted therapy;Ross;Oncologist,2017

5. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer;Koivunen;Clin. Cancer Res.,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of circulating biomarkers in non-small cell lung cancer;Frontiers in Cell and Developmental Biology;2024-08-21

2. Fusion Challenges in Solid Tumors: Shaping the Landscape of Cancer Care in Precision Medicine;JCO Precision Oncology;2024-07

3. Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib‐refractory ALK‐positive NSCLC from a phase II study;Cancer Communications;2024-02-29

4. Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types;Clinical Cancer Research;2024-01-09

5. A quadratic isothermal amplification fluorescent biosensor without intermediate purification for ultrasensitive detection of circulating tumor DNA;The Analyst;2024